Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 697 to 699 of 699 entries
Sorted by: Best Match Show Resources per page
Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer's Disease.

Frontiers in pharmacology

Caruso G, Grasso M, Fidilio A, Torrisi SA, Musso N, Geraci F, Tropea MR, Privitera A, Tascedda F, Puzzo D, Salomone S, Drago F, Leggio GM, Caraci F.
PMID: 35002742
Front Pharmacol. 2021 Dec 24;12:809541. doi: 10.3389/fphar.2021.809541. eCollection 2021.

Depression is a risk factor for the development of Alzheimer's disease (AD). A neurobiological and clinical continuum exists between AD and depression, with neuroinflammation and oxidative stress being involved in both diseases. Second-generation antidepressants, in particular selective serotonin reuptake...

Cite
Caruso G, Grasso M, Fidilio A, et al. Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer's Disease. Front Pharmacol. 2021;12:809541doi: 10.3389/fphar.2021.809541.
Caruso, G., Grasso, M., Fidilio, A., Torrisi, S. A., Musso, N., Geraci, F., Tropea, M. R., Privitera, A., Tascedda, F., Puzzo, D., Salomone, S., Drago, F., Leggio, G. M., & Caraci, F. (2021). Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer's Disease. Frontiers in pharmacology, 12809541. https://doi.org/10.3389/fphar.2021.809541
Caruso, Giuseppe, et al. "Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer's Disease." Frontiers in pharmacology vol. 12 (2021): 809541. doi: https://doi.org/10.3389/fphar.2021.809541
Caruso G, Grasso M, Fidilio A, Torrisi SA, Musso N, Geraci F, Tropea MR, Privitera A, Tascedda F, Puzzo D, Salomone S, Drago F, Leggio GM, Caraci F. Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer's Disease. Front Pharmacol. 2021 Dec 24;12:809541. doi: 10.3389/fphar.2021.809541. eCollection 2021. PMID: 35002742; PMCID: PMC8740153.
Copy Download .nbib Format: NLM
Efficacy of Transcutaneous Electrical Nerve Stimulation for Postoperative Pain, Pulmonary Function, and Opioid Consumption Following Cardiothoracic Procedures: A Systematic Review.

Neuromodulation : journal of the International Neuromodulation Society

Cardinali A, Celini D, Chaplik M, Grasso E, Nemec EC.
PMID: 33215794
Neuromodulation. 2021 Dec;24(8):1439-1450. doi: 10.1111/ner.13302. Epub 2020 Nov 20.

OBJECTIVE: Transcutaneous electrical nerve stimulation (TENS) is a minimally invasive method for treating pain. In the most recent review published in 2012, TENS was associated with increased pain relief following cardiothoracic surgery when compared to standard multimodal analgesia. The...

Cite
Cardinali A, Celini D, Chaplik M, et al. Efficacy of Transcutaneous Electrical Nerve Stimulation for Postoperative Pain, Pulmonary Function, and Opioid Consumption Following Cardiothoracic Procedures: A Systematic Review. Neuromodulation. 2020;24(8):1439-1450doi: 10.1111/ner.13302.
Cardinali, A., Celini, D., Chaplik, M., Grasso, E., & Nemec, E. C. (2021). Efficacy of Transcutaneous Electrical Nerve Stimulation for Postoperative Pain, Pulmonary Function, and Opioid Consumption Following Cardiothoracic Procedures: A Systematic Review. Neuromodulation : journal of the International Neuromodulation Society, 24(8), 1439-1450. https://doi.org/10.1111/ner.13302
Cardinali, Alexis, et al. "Efficacy of Transcutaneous Electrical Nerve Stimulation for Postoperative Pain, Pulmonary Function, and Opioid Consumption Following Cardiothoracic Procedures: A Systematic Review." Neuromodulation : journal of the International Neuromodulation Society vol. 24,8 (2021): 1439-1450. doi: https://doi.org/10.1111/ner.13302
Cardinali A, Celini D, Chaplik M, Grasso E, Nemec EC. Efficacy of Transcutaneous Electrical Nerve Stimulation for Postoperative Pain, Pulmonary Function, and Opioid Consumption Following Cardiothoracic Procedures: A Systematic Review. Neuromodulation. 2021 Dec;24(8):1439-1450. doi: 10.1111/ner.13302. Epub 2020 Nov 20. PMID: 33215794.
Copy Download .nbib Format: NLM
Perspectives and Experiences of Transgender and Non-binary Individuals on Seeking Urological Care.

Urology

Chung PH, Spigner S, Swaminathan V, Teplitsky S, Frasso R.
PMID: 33129873
Urology. 2021 Feb;148:47-52. doi: 10.1016/j.urology.2020.10.026. Epub 2020 Oct 28.

OBJECTIVE: To describe perspectives and experiences related to urology care-seeking of transgender and non-binary (TGNB) individuals assigned male at birth.MATERIALS AND METHODS: This HIPAA-compliant study was IRB approved and followed Consolidated Criteria for Reporting Qualitative Studies (COREQ) guidelines. Through...

Cite
Chung PH, Spigner S, Swaminathan V, et al. Perspectives and Experiences of Transgender and Non-binary Individuals on Seeking Urological Care. Urology. 2020;148:47-52doi: 10.1016/j.urology.2020.10.026.
Chung, P. H., Spigner, S., Swaminathan, V., Teplitsky, S., & Frasso, R. (2021). Perspectives and Experiences of Transgender and Non-binary Individuals on Seeking Urological Care. Urology, 14847-52. https://doi.org/10.1016/j.urology.2020.10.026
Chung, Paul H, et al. "Perspectives and Experiences of Transgender and Non-binary Individuals on Seeking Urological Care." Urology vol. 148 (2021): 47-52. doi: https://doi.org/10.1016/j.urology.2020.10.026
Chung PH, Spigner S, Swaminathan V, Teplitsky S, Frasso R. Perspectives and Experiences of Transgender and Non-binary Individuals on Seeking Urological Care. Urology. 2021 Feb;148:47-52. doi: 10.1016/j.urology.2020.10.026. Epub 2020 Oct 28. PMID: 33129873.
Copy Download .nbib Format: NLM
Showing 697 to 699 of 699 entries